Expert Review of Anticancer Therapy

期刊全称Expert Review of Anticancer Therapy
期刊缩写EXPERT REV ANTICANC
涉及主题医学内科学生物遗传学肿瘤科癌症病理外科化学癌症研究免疫学生物化学化疗放射科生物信息学
期刊介绍

Expert Review of Anticancer Therapy (ISSN 1473-7140) provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches. Coverage includes tumor management, novel medicines, anticancer agents and chemotherapy, biological therapy, cancer vaccines, therapeutic indications, biomarkers and diagnostics, and treatment guidelines. All articles are subject to rigorous peer-review, and the journal makes an essential contribution to decision-making in cancer care. Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections: Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results Article Highlights – an executive summary of the author’s most critical points.

期刊ISSNprint: 1473-7140
历年影响因子
2024年 2023年 2022年 2021年 2020年 2019年 2018年 2017年
2.93.33.6274.5123.5732.5712.3472.212
历年发表/被引量
年份20252024202320222021202020192018201720162015201420132012
发表量9211811511710415687128120136145155175178
被引量17804626541455035346468737853474333132343329317332433065
h-Index59
自引率0.00%
涉及的研究领域医学-肿瘤学
中科院2025年分区 ?
大类小类TOP期刊综述期刊
4区4区 肿瘤学
WOS期刊分区

JCR学科分类

JCR分区学科名称收录数据库JCR分区分区排名
ONCOLOGYSCIEQ2160/326

JCI学科分类

JCI分区学科名称收录数据库JCI分区分区排名
ONCOLOGYSCIEQ3210/326
期刊主页http://www.tandfonline.com/toc/iery20/current#.V48dKEz9cSQhttp://informahealthcare.com/journal/ery
投稿网址https://mc.manuscriptcentral.com/ert
出版商Taylor and Francis Ltd.
出版国家(地区)ENGLAND
出版语言English
出版周期Bimonthly
每年出版文章数99
Gold OA文章占比10.86%
原创研究文献占比
(排除综述)
34.91%
SCI收录类型

Science Citation Index Expanded (SCIE)

Scopus (CiteScore)

PubMed链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1473-7140%5BISSN%5D
平均审稿周期偏慢,4-8周
平均录用比例容易
相关链接

您可以在上述网站查看该期刊的网友互动,及期刊影响力的其它指标。

注:上述信息均来源于网络,仅供查考,如有遗漏或信息错误,欢迎 向我反馈